Sélection de la langue

Search

Sommaire du brevet 2118207 

Énoncé de désistement de responsabilité concernant l'information provenant de tiers

Une partie des informations de ce site Web a été fournie par des sources externes. Le gouvernement du Canada n'assume aucune responsabilité concernant la précision, l'actualité ou la fiabilité des informations fournies par les sources externes. Les utilisateurs qui désirent employer cette information devraient consulter directement la source des informations. Le contenu fourni par les sources externes n'est pas assujetti aux exigences sur les langues officielles, la protection des renseignements personnels et l'accessibilité.

Disponibilité de l'Abrégé et des Revendications

L'apparition de différences dans le texte et l'image des Revendications et de l'Abrégé dépend du moment auquel le document est publié. Les textes des Revendications et de l'Abrégé sont affichés :

  • lorsque la demande peut être examinée par le public;
  • lorsque le brevet est émis (délivrance).
(12) Brevet: (11) CA 2118207
(54) Titre français: BACILLUS THURINGIENSIS M200 DESTINE A LA LUTTE BIOLOGIQUE CONTRE LES INSECTES NUISIBLES EN AGRICULTURE ET EN HORTICULTURE
(54) Titre anglais: BACILLUS THURINGIENSIS M200 FOR THE BIOLOGICAL CONTROL OF AGRICULTURAL AND HORTICULTURAL ENTOMOLOGICAL PESTS
Statut: Durée expirée - au-delà du délai suivant l'octroi
Données bibliographiques
(51) Classification internationale des brevets (CIB):
  • C12N 1/20 (2006.01)
  • A1N 37/18 (2006.01)
  • C7K 14/32 (2006.01)
  • C7K 14/325 (2006.01)
(72) Inventeurs :
  • MEADOWS, MARTIN P. (Royaume-Uni)
  • ELLIS, DEBORAH J. (Royaume-Uni)
  • JARRETT, PAUL (Royaume-Uni)
(73) Titulaires :
  • THE MICROBIO GROUP LIMITED
(71) Demandeurs :
  • THE MICROBIO GROUP LIMITED (Royaume-Uni)
(74) Agent: SMART & BIGGAR LP
(74) Co-agent:
(45) Délivré: 1998-09-22
(22) Date de dépôt: 1994-10-14
(41) Mise à la disponibilité du public: 1996-04-15
Requête d'examen: 1995-01-17
Licence disponible: S.O.
Cédé au domaine public: S.O.
(25) Langue des documents déposés: Anglais

Traité de coopération en matière de brevets (PCT): Non

(30) Données de priorité de la demande: S.O.

Abrégés

Abrégé français

L'invention a trait à une souche de Bacillus thuringiensis M200, dont un échantillon a été déposé sous le numéro d'entrée NCIMB 40485, ou une souche recombinante ou mutante de ce bacille ayant une activité insecticide contre les espèces de lépidoptères nuisibles. L'invention a également trait à l'usage de la souche ou de la souche recombinante ou mutante dans la lutte contre les insectes nuisibles.


Abrégé anglais


The invention relates to a strain of Bacillus
thuringiensis M200, a sample of which has been deposited under
the accession number NCIMB 40385, or a recombinant or mutant
thereof having entomocidal activity against lepidopterous
pests. The invention also relates to the use of the strain,
recombinant or mutant in control of insect pests.

Revendications

Note : Les revendications sont présentées dans la langue officielle dans laquelle elles ont été soumises.


THE EMBODIMENTS OF THE INVENTION IN WHICH AN EXCLUSIVE
PROPERTY OR PRIVILEGE IS CLAIMED ARE DEFINED AS FOLLOWS:
1. A strain of Bacillus thuringiensis M200, a sample of
which has been deposited under the accession number NCIMB
40385, or a recombinant or mutant thereof having entomocidal
activity against lepidopterous pests.
2. An entomocidal substance derived from Bacillus
thuringiensis strain M200 (NCIMB 40385), or from a recombinant
or mutant thereof, the entomocidal substance being a
spore-crystal complex.
3. The use of Bacillus thuringiensis strain M200 (NCIMB
40385), or a recombinant or mutant thereof, for control of
insect pests susceptible to M200 including insect pests
selected from the group consisting of Plutella xylostella,
Pieris rapae, Pieris brassicae and Trichoplusia ni.
4. An entomocidal composition comprising Bacillus
thuringiensis strain M200 (NCIMB 40385), or a recombinant or
mutant thereof, or an entomocidal substance according to
claim 2, together with a carrier, diluent, surfactant or
application-promoting adjuvant.
5. An entomocidal composition according to claim 4 in
the form of a wettable powder comprising from 25 to 75% by
weight of Bacillus thuringiensis M200, or a recombinant or
- 18 -

mutant thereof, or an entomocial substance derivable from
Bacillus thuringiensis strain M200 (NCIMB 40385), or from a
recombinant or mutant thereof, said entomocidal substance
being a spore-crystal complex, from 0 to 5% by weight of
sodium lignosulfate, from 0 to 5% by weight of sodium
laurylsulfate, from 0 to 10% by weight of sodium
diisobutylnapthalene sulfonate, from 0 to 2% by weight of
octylphenol polyethylene glycol ether (7-8 moles of ethylene
oxide), from 5 to 10% by weight of highly dispersed silicic
acid; and from 0 to 62% by weight of kaolin.
- 18a -

6. A composition according to claim 4, also containing a further biologically active
compound selected from fertilisers, micronutrient donors, plant growth preparations,
herbicides, insecticides, fungicides, bactericides, nematicides and molluscicides and
mixtures thereof.
7. A composition according to claim 4, comprising from 0.1 to 99% by weight of Bacillus
thuringiensis M200 or a recombinant or mutant thereof, or an entomocidal substance
according to claim 2, from 1 to 99% by weight of a solid or liquid adjuvant; and from 0 to
25% by weight of a surfactant.
8. A method of combatting lepidopterous pests which comprises applying to the pests or to
their environment an entomocidally effective amount of Bacillus thuringiensis strain M200
(NCIMB 40385), or a recombinant or mutant thereof, or an entomocidal substance
according to claim 2, or a composition containing said strain, recombinant, mutant or
substance.
- 19-

Description

Note : Les descriptions sont présentées dans la langue officielle dans laquelle elles ont été soumises.


CA 02ll8207 l998-04-06
BIOLOGICAL CONTROL OF PESTS
This invention relates to biological methods of pest
control and more particularly to methods and compositions
utilising Bacillus thuringiensis for the control of
agricultural and horticultural pests.
Bacillus thuringiensis is a spore forming bacterium
which has long been known to kill insects and many hundreds of
isolates (strains) of this species have been listed. The
properties of individual B. thuringiensis strains and their
activity against insect pests vary widely from strain to
strain.
We have now isolated a new strain of Bacillus
thuringiensis which has been found to be highly active against
agricultural and horticultural pests including those of the
family Pieridae, including Pieris brassicae (Large White
Butterfly), and pests of the family Yponomeutidae, including
Plutella xylostella (Diamond-back moth). The activity of the
new strain, designated M200, is several-fold greater towards
the above pests than many known strains of B. thuringiensis
including those used commercially and those under current
development which have been described in the literature.
The present invention comprises Bacillus
thuringiensis strain M200 a sample of which has been deposited
under the Budapest Treaty with the National Collection of
Industrial and Marine Bacteria under Accession No. NCIMB
40385, on 20 March 1991.
The present invention also comprises the use of B.
thuringiensis strain M200 for the control of pests which
21489-9160

CA 02118207 1998-04-06
affect plants. Accordingly the invention comprises a method
of pest control in which agricultural and horticultural
produce are protected against pests by application of this new
strain to the growing plants or other horticultural products
or to their growing locations. The invention also comprises
compositions containing the new strain and formulated for
agricultural or
la
21489-9160

2118207
horticultural app' ~rticln. The invention is applicable also to variants, mutants and recombinants
of the new strain which are similarly biologically effective.
A recombinant of strain M200 is one which is produced when the strain has been used as a
recipient for additional genetic material in the form of an additional plasmid. For example, the
additional plasmid can be transferred by plasmid transfer (conjugation) from another Bt strain,
or the additional plasmid can contain eg a cloned toxin gene prepared by recombinant DNA
techniques and inserted into the recipient strain by transformation using techniques well known
to those skilled in the art. In both cases, the recipient strain retains its original genetic material
and thus the same insecticidal activity of the original strain is maintained. Of course, additional
or enhanced insecticidal activity may be present in the recombinant strain by virtue of the added
genetic material.
The invention will now be further described.
The strain Bacillus thuringiensis M200 has the H-serotype 3a3b. When grown for 24h at 30~C
on nutrient agar the colonies are circular, entire, convex, off-white, have a ground glass
appearance and a diameter of 2-8mm. The vegetative cells are Gram-positive aerobic rods
producing sub-terminal spores towards the end of the growth cycle. At the same time as
sporulation, a parasporal, proteinaceous crystal is produced which is approximately the same
size as the spore.

2 ~ 7
biochemical profile of M200 on standard substrates (API ZONE test strip) is shown below.
HD1 is a commercially available strain.
Strain Code No.
Reaction
M200 HD1
NO3 (nitrate reduction) +
TRP (indole production)
GLU (glucose acidification)
ADH (arginine dihydrolase) +
URE (urease)
ESC (esculin hydrolysis) +
GEL (gelatine hydrolysis) + +
PNPG (,~-glactosidase)
GLU (glucose assimilation) + +
ARA (arabinose assimilation)
MNE (mannose assimilation)
MAN (mannitol assimilation)
NAG (N-acetyl glucosamine assimilation) + +
MAL(maltose assimilation) + +
GNT (gluconate assimilation) + +
CAP (caprate assimilation)
ADI (adipate assimilation)
MLT (malate assimilation) + +
CIT (citrate assimilation)
PAC (phenylacetate assimilation)
* Trade - ma rk
21489-9160
B

2118~07
B. thuringiensis strains produce a number of proteins which are toxic to insects. There is an
internationally recognised classification for these toxins. By the use of specific DNA probes it
is possible to determine which toxin genes a particular strain possesses. The major toxin gene
content of strains HD1 and M200 is compared below.
HD1: CRY 1A(a), CRY 1A(b), CRY 1A(c), CRYIIA
M200: CRY 1A(a), CRY 1 A(b) [not expressed], CRY 1A(c), CRY 1 E(c), CRYIIA
B. thuringiensis can be produced on a large scale by submerged fermentation using processes
such as those described by Lee et al in Microbial Biomass [1979, A.H. Rose (ed). Academic
Press pp 91-114]. Typical growth media may contain any of the following ingredients in various
combinations: fishmeal, cottonseed meal, soybean meal, molasses, diammonium phosphate,
starch. During production by fermentation, after normal growth of Bacillus thuringiensis, the
mother cells Iyse and release the spores and crystals into the growth medium. The spores and
crystals may be harvested by centrifugation or filtration, spray drying, vacuum drying, or a
method of precipitation, such as the lactose coprecipitation technique as reported by Dulmage
etal(Joumal of Invertebrate Pathology, 15, 15-20, 1970). The resulting spore-crystal complex
is stable for long periods and can be formulated into a product suitable for application to crops.
The invention also includes the use of delta endotoxins derived from the above-mentioned new
organism. The invention provides an entomocidal substance derived from Bacillus thuringiensis
strain M200, or from a recombinant or mutant thereof. In one embodiment the entomocidal
substance is a spore-crystal complex. The spore-crystal complex or the composition containing
it may be administered to the plants or crops to be protected together with certain other
insecticides or chemicals without loss or potency.

2118207
It is possible to kill the spores in the spore-crystal (eg by gamma irradiation), or to avoid
producing spores by use of an asporogenous crystaliferous mutant, thereby producing a non-
viable product. A non-viable product may be advantageous in certain circumstances where it is
desired to prevent the spread of bacteria for aesthetic reasons or to avoid causing disease in
beneficial insects. However, non-viable products are generally not as active as those containing
live spores and as a further disadvantage there is the increased cost of killing the spores.
The invention further provides an entomocidal substance derived from Bacillus thuringiensis
strain M200 (NCIMB 40385) or a recombinant or mutant thereof, or an entomocidal substance
as defined above together with an agricultural adjuvant such as a carrier, diluent, surfactant or
application-promoting adjuvant. The composition may also contain a further biologically active
compound selected from fertilisers, micronutrient donors, plant growth preparations, herbicides,
insecticides, fungicides, bactericides, nematicides and molluscicides and mixtures thereof. The
composition may comprise from 0.1 to 99% by weight of Bacillus thuringiensis M200 or the
recombinant or mutant thereof, or the entomocidal substance; from 1 to 99.9% by weight of a
solid or liquid adjuvant and from 0 to 25% by weight of a surfactant.
The invention in addition provides a method of combatting pests which comprises applying to the
pests or to their environment an entomocidally effective amount of Bacillus thuringiensis strain
M200, or a I~COl 1 Ib-. ,ant or mutant thereof, or an entomocidal substance as defined above, or a
composition containing said strain, recombinant, mutant or substance.
Bacillus thuringiensis strain M200 or the compositions containing it may be administered to the
plants or crops to be protected together with certain other insecticides or chemicals without loss
of potency. It is compatible with most other commonly used agricultural spray materials but
should not be used in extremely alkaline spray solutions. It may be administered as a dust, a

~118207
suspension, a wettable powder or in any other material form suitable for agricultural application.
The invention furthermore relates to a method of treating crops which comprises applying an
entomocidally effective amount of B. thuringiensis M200, or a composition thereof.
Bacillus thuringiensis M200, is normally applied in the form of compositions and can be applied
to the crop area to be treated, simultaneously or in succession, with further biologically active
compounds. These compounds may be both fertilisers or micronutrient donors or other
preparations that influence plant growth. They may also be selective herbicides, insecticides,
fungicides, bactericides, nemAticides, ~ uscicWes or mixtures of several of these preparations,
if desired, together with further carriers, surfactants or application-promoting adjuvants
customarily employed in the art of formulation. Suitable carriers and adjuvants can be solid or
liquid and correspond to the substances ordinarily employed in formulation technology, eg natural
or regenerated mineral substances, solvents, dispersants, wetting agents, takifiers, binders or
fertilisers.
The fommulations, ie the compositions, preparations or mixtures containing B. thuringiensis M200
as an active ingredient or combinations thereof with other active ingredients, and, where
appropriate, a solid or liquid adjuvant, are prepared in known manner eg by homogeneously
mixing and/or grinding the active ingredients with extenders eg solvents, solid carriers and in
some cases surface-acting compounds (surfactants).
Suitable solvents are: aromatic hydrocarbons, preferably the fractions containing 8 to 12 carbon
atoms, eg xylene mixtures or substituted napthalenes, phthalates such as dibutylphthalate or
dioctylphthalate, aliphatic hydrocarbons such as cyclohexane or paraffins, alcohols and glycols,
such as cyclohexanone, strongly polar solvents such as N-methyl-2-pyrrolidone,

~118207
dimethylsufoxide or dimethylformamide as well as vegetable oils or epoxidised vegetable oils
such as epoxidised coconut oil or soybean oil; or water.
The solid carriers used eg for dusts and dispersable powders, are normally natural mineral fillers
such as calcite, talcum, kaolin, montmorillonite or attapulgite. In order to improve the physical
properties it is also possible to add highly dispersed silicic acid or highly dispersed absorbent
polymers. Suitable granulated adsorptive carriers are porous types, for example pumice, broken
brick, sepiolite or bentonite; and suitable nonsorbent carriers are materials such as calcite or
sand. In addition, a great number of pregranulated materials of inorganic or organic nature can
be used, eg especially dolomite or pulverised plant residues.
Depending on the nature of the active ingredients to be formulated, suitable surface-active
compounds are non-ionic, cationic and/or anionic surfactants having good emulsifying, dispersing
and wetting properties. The term "surfactants" will also be understood as comprising mixtures
of surfactants.
Suitable anionic surfactants can be both water-soluble soaps and water-soluble synthetic
surface-acting compounds. Suitable soaps are the alkali metal salts, alkaline earth metal salts
or unsubstituted or substituted ammonium salts of higher fatty acids (C10-C22), eg the sodium or
potassium salts of oleic or stearic acid, or of natural fatty acid mixtures which can be obtained,
eg from coconut oil or tallow oil. Further suitable surfactants are also the fatty acid methyltaurin
salts as well as modified and unmodified phospholipids. More frequently, however, so-called
surfactants are used, especially fatty sulfonates, fatty sulfates, sulfonated benzimidazole
derivatives or alkylaryl-sulfonates.

2II8207
The fatty sulfonates or sulfates are usually in the forms of alkali metal salts, alkaline earth metal
salts or unsubstituted or substituted a,~ ,on -lrn salts and generally contain a C8-C22 alkyl radical
which also includes the alkyl moiety of acyl radicals, eg the sodium or calcium salt of
lignosulfonic acid, or dodecylsufate, or of a mixture of fatty alcohol sulfates obtained from natural
fatty acids. These compounds also comprise the salts of sulfuric acid esters and sulfonic acids
of fatty alcohol/ethylene oxide adducts. The sulfonated benzimidazole derivatives preferably
contain 2 sulfonic acid groups and one fatty acid radical containing about 8 to 22 carbon atoms.
Examples of alkyl-arylsufonates are the sodium, calcium or triethanolamine salts of
dodecylbenzenesulfonic acid, dibutylnapththalenesulfonic acid or of a naphthalenesulfonic
acid/fo",~ldehyde condensation product. Also suitable are corresponding phosphates, eg salts
of the phosphoric acid ester of an adduct of p-nonylphenol with 4 to 14 moles of ethylene oxide.
Non-ionic surfactants are preferably polyglycol ether derivatives of aliphatic or cycloaliphatic
alcohols or saturated or unsaturated fatty acids and alkylphenols, said derivatives containing 3
to 30 glycol ether groups and 8 to 20 carbon atoms in the (aliphatic) hydrocarbon moiety and 6
to 18 carbon atoms in the alkyl moiety of the alkylphenols.
Further suitable non-ionic surfactants are the water-soluble adducts of polyethylene oxide with
polypropylene glycol, ethylenediaminopolypropylene glycol and alkylpolypropylene glycol
containing 1 to 10 carbon atoms in the alkyl chain, which adducts contain 20 to 250 ethylene
glycol ether groups and 10 to 100 propylene glycol ether groups. These compounds usually
contain 1 to 5 ethylene glycol units per propylene glycol unit.
Representative examples of non-ionic surfactants are nonylphenolpolyethoxyethanols, castor oil
polyglycol ethers, polypropylene/polyethylene oxide adducts, tributylphenoxypolyethoxyethanol,
polyethylene glycol and octylphenoxypolyethoxyethanol. Fatty acid esters of polyoxyethylene

2118207
sorbitan, such as polyoxyethylene sorbitan-trioleate, are also suitable non-ionic surfactants.
Cationic surfactants are preferably quaternary ammonium salts which contain, as N-substituent,
at least one C8-Cz alkyl radical and, as further substituents, lower unsubstituted or halogenated
alkyl, benzyl or hydroxyl-lower alkyl radicals. The salts are preferably in the form of halides,
methylsulfates or ethylsulfates eg stearyltrimethylammonium chloride or benzyldi-(2-
chloroethyl)ethylammonium bromide.
The surfactants customarily employed in the art of formulation are described eg in "McCutcheon's
Detergents and Emulsifiers Annual", MC Publishing Corp, Ridgewood, New Jersey, 1979; Dr
Helmut Stache, "Tensid Taschenbuch" (Handbook of Surfactants), Carl Hanser Verlag,
MunichNienna.
The entomocidal compositions usually contain 0.1 to 99%, preferably 0.1 to 95% of Bacillus
thuringiensis M200, or combination thereof with other active ingredients, 1 to 99.9% of a solid
or liquid adjuvant and 0 to 25%, preferably 0.1 to 20%, of a surfactant.
Whereas commercial products are preferably formulated as concentrates, the end user will
normally employ dilute formulations of substantially lower concentration.
The compositions may also contain further ingredients, such as stabilisers, antifoams, viscosity
regulators, binders, tackifiers as well as fertilisers or other active ingredients in order to obtain
special effects.
The invention will now be further described with reference to experimental and field test data
obtained in comparative testing of isolate M200 and of other B. thuringiensis isolates.

~118207
FY~nple 1 - Large Scale Culture of B. thuringiensis
Bacillus thuringiensis strain M200 can be cultured on a large scale as follows:
The strain is maintained in Iyophilized ampoules, which are used as stocks for inoculating the
strain onto agar slopes. The slopes are incubated for 1 to 5 days at 20 to 40~C, preferably 25
to 33~C, following which they are used to inoculate shaken flasks containing an aqueous culture
medium. Typical growth media might contain the following ingredients in various combinations:
3-5% fishmeal, 2-3% cottonseed meal, 2-3% soybean meal, 2-4% molasses, 1% diammonium
phosphate and 0.5-1% starch. The flasks are shaken at a temperature of 20 to 40~C preferably
30~C for 1 to 5, preferably 1 to 2 days (this vegetative growth stage can be repeated optionally
at least once in a separate flask), and used to inoculate a preculture fermenter containing an
aqueous cultivating medium. The fermentation medium containing the inoculate is stirred and
aerated at a temperature of 20 to 40~C, preferably 30 to 35~C, (optionally this preculture
fermentation stage can be repeated at least once in a separate larger container), before being
introduced at 2 to 20 per cent by weight of the incubating liquor into a production fermenter,
containing an aqueous cultivating medium. The medium is stirred and aerated at a temperature
of 20 to 40~C, preferably 30 to 35~C until the Bacillus thuringiensis M200 broth is harvested when
sporulation and crystal production in the production fermenter reaches a maximum. The agar
and broth used for preparation of inocula for the preculture fermenter should contain at least one
nitrogen source, at least one carbon source and at least one salt, preferably peptone, glucose
and at least one salt. The fermentation media should contain at least one nitrogen source (eg
peptone, yeast extract, corn steep liquor, soya bean meal, cotton seed meal, fishmeal), at least
one carbohydrate source (eg glucose, lactose, sucrose, starch or raw material rich in these
constituents) at at least one mineral salt. The nitrogen and carbohydrate should be balanced to
- 10-

2118207
exhaust as near as possible simultaneously. Cultures can be concentrated after harvesting by
centrifugation to produce a slurry containing a spore/crystal concentrate. The concentrate can
be converted into a dry powder by spray-drying.
Example 2 - Insect Bioassays
The activity of B. thuringiensis strain M200 against the insects Pieris brassicae and Plutella
xylostella was compared in bioassays with the commercially available strain HD1. Bacterial
powders were prepared as described in Example 1 and activities against insects assayed by the
addition of a series of concentrations of the powders to artificial diets on which the larvae fed.
For P. brassicae the semi-synthetic diet of David, W.A.L. and Gardiner, R.O.C. (1965), [Nature,
London 207, No 4999, pp 882-883] was used. All larvae used in bioassays were neonates.
Mortality was recorded after 5 days with the temperature maintained at 25~C. For P. xylostella
the same semi-synthetic diet was used, except that all antibiotics were omitted, but all larvae
used in bioassays were at the beginning of the third instar. Mortality was recorded after 5 days
with the temperature maintained at 25~C.
It can be seen from the results expressed in Table 1 that the activity of B. thuringiensis strain
M200 towards P. brassicae is 2.5 to 4-fold greater than that of HD1. Similarly the activity of B.
thuringiensis strain M200 towards P. xylostella is 1 6-fold greater than that of HD1.

- ~118207
Example 3 - Formulation exa"--ples for solid active ingredients of Bacillus thurin~iensis
M200 or cG~IlJinations thereof with other active ingredients
(throughout, percentages are by weight)
1. Wettable powders
a) b) c)
Bacillus thuringiensisM200 25% 50% 75%
sodiumlignosulfonate 5% 5%
sodium laurylsulfate 3% - 5%
sodium diisobutylnapthalenesulfonate - 6% 10%
octylphenol polyethylene glycol ether
(7-8 moles of ethylene oxide) - 2%
highly dispersed silicic acid 5% 10% 10%
kaolin 62% 27%
Bacillus thunngiensis M200, is thoroughly mixed with the adjuvants and the mixture is thoroughly
ground in a suitable mill, affording wettable powders which can be diluted with water to give
suspensions of the desired concentration.
- 12-

2118207
2. Fmulsifiable concentrate
Bacillus thuringiensis M200 10%
octylphenol polyethylene glycol ether (4-5 moles of ethylene oxide) 3%
calcium dodecylbenzenesulfonate 3%
castor oil polyglycol ether (36 moles of ethylene oxide) 4%
cyclohexanone 30%
xylene mixture 50%
Emulsions of any required concentration can be obtained from this concentrate by dilution with
water.
3. Dusts
a) b)
Bacillus thuringiensisM200 5% 8%
talcum 95%
kaolin - 92%
Ready for use dusts are obtained by mixing the active ingredient with the carriers and grinding
the mixture in a suitable mill.
- 13-

2I18~7
4. Extruder Qranulate
Bacillus thuringiensis M200 10%
sodium lignosulfonate 2%
carboxymethylcellulose 1 %
kaolin 87%
The active ingredient or combination is mixed and ground with the adjuvants and the mixture is
subsequently moistened with water. The mixture is extruded, granulated and then dried in a
stream of air.
5. Coated granule
Bacillus thuringiensis M200 3%
polyethylene glycol (mol. wt. 200) 3%
kaolin 94%
The finely ground active ingredient or combination is uniformly applied in a mixer to the kaolin
moistened with polyethylene glycol. Non-dusty coated granulates are obtained in this manner.
- 14-

2t.I8207
6. Suspension Concentrate
Bacillus thuringiensis M200 40%
ethylene glycol 10%
nonylphenol polyethylene glycol ether (15 moles of ethylene oxide) 6%
sodium lignosulfonate 10%
carboxymethylcellulose 1 %
37% aqueous formaldehyde solution 0.2%
silicone oil in the form of a 75% aqueous emulsion 0.8%
water 32%
The finely ground active ingredient or combination is intimately mixed with the adjuvants giving
a suspension concer,l,ale from which suspensions of any desired concentration can be obtained
by dilution with water.
Example 4 - Field Trials
Bacillus thuringiensis strain M200 was prepared as a wettable powder formulation using the
method described in Example 3. This fommulation contained 25% by weight of strain M200. The
strain was tested for control of P. xylostella, Pieris rapae and Trichoplusia ni in a series of field
trials on cabbages. The results, expressed as percentage control of insect larvae, are
summarised in Table 2. These results clearly indicate that, in the field, strain M200 is highly
active against the insect pests tested. The wettable powder used in these trials represents only
one example of an effective formulation, preparation of many other effective formulations will be
known to those skilled in the art.

~1 18207
Table 1
Activity of Bacillus thurinyiensis M200 against Pieris brassicae and Plutella xylostella
LC50 of Isolate
Isolate
(Fiducial limits)
P. bra-ssie~e
M200 0.16 (0.07 - 0.26)
M200 (replicate) 0.096 (0.038 - 0.17)
HD1 0.40 (0.30 - 0.50)
P. xylostella
M200 0.07 (0.014 - 0.50)
HD1 1 .32 (0.95 -1 .83)
LC50 is expressed as the dose of B. thuringiensis powder (~g per g diet) which gave 50%
mortality.
- 16-

21 18207
Table 2
Activity of B. thuri"giensis strain M200 in field trials against Plutella xylostella, Pieris
rapae and Trichoplusia nion caL,~age
Application Rate % Control
Strain
(Ib/acre) P. xylostella T. ni P. rapae
0.25 84.3 - 100.0
0.50 93.9 - 97.0
M200'
1.00 95.0 83.5 100.0
1.50 - 93 7
Wettable powder containing 25% B. thuringiensis strain M200 and prepared as described in
Example 3.

Dessin représentatif

Désolé, le dessin représentatif concernant le document de brevet no 2118207 est introuvable.

États administratifs

2024-08-01 : Dans le cadre de la transition vers les Brevets de nouvelle génération (BNG), la base de données sur les brevets canadiens (BDBC) contient désormais un Historique d'événement plus détaillé, qui reproduit le Journal des événements de notre nouvelle solution interne.

Veuillez noter que les événements débutant par « Inactive : » se réfèrent à des événements qui ne sont plus utilisés dans notre nouvelle solution interne.

Pour une meilleure compréhension de l'état de la demande ou brevet qui figure sur cette page, la rubrique Mise en garde , et les descriptions de Brevet , Historique d'événement , Taxes périodiques et Historique des paiements devraient être consultées.

Historique d'événement

Description Date
Inactive : CIB expirée 2020-01-01
Inactive : CIB expirée 2020-01-01
Inactive : Périmé (brevet - nouvelle loi) 2014-10-14
Lettre envoyée 2012-10-09
Inactive : Transfert individuel 2012-09-12
Inactive : CIB de MCD 2006-03-11
Accordé par délivrance 1998-09-22
Inactive : Taxe finale reçue 1998-04-06
Inactive : Pages reçues à l'acceptation 1998-04-06
Préoctroi 1998-04-06
Un avis d'acceptation est envoyé 1997-10-07
Un avis d'acceptation est envoyé 1997-10-07
month 1997-10-07
Lettre envoyée 1997-10-07
Inactive : Renseign. sur l'état - Complets dès date d'ent. journ. 1997-10-02
Inactive : Dem. traitée sur TS dès date d'ent. journal 1997-10-02
Inactive : CIB attribuée 1997-08-08
Inactive : Approuvée aux fins d'acceptation (AFA) 1997-08-08
Inactive : CIB attribuée 1997-08-08
Inactive : CIB en 1re position 1997-08-08
Inactive : CIB enlevée 1997-08-08
Inactive : CIB enlevée 1997-08-08
Inactive : CIB attribuée 1997-08-08
Inactive : CIB enlevée 1997-08-08
Inactive : CIB enlevée 1997-08-08
Inactive : CIB attribuée 1997-08-08
Inactive : CIB enlevée 1997-08-08
Inactive : CIB attribuée 1997-08-08
Inactive : CIB enlevée 1997-08-08
Inactive : CIB enlevée 1997-08-08
Demande publiée (accessible au public) 1996-04-15
Toutes les exigences pour l'examen - jugée conforme 1995-01-17
Exigences pour une requête d'examen - jugée conforme 1995-01-17

Historique d'abandonnement

Il n'y a pas d'historique d'abandonnement

Taxes périodiques

Le dernier paiement a été reçu le 1998-08-28

Avis : Si le paiement en totalité n'a pas été reçu au plus tard à la date indiquée, une taxe supplémentaire peut être imposée, soit une des taxes suivantes :

  • taxe de rétablissement ;
  • taxe pour paiement en souffrance ; ou
  • taxe additionnelle pour le renversement d'une péremption réputée.

Les taxes sur les brevets sont ajustées au 1er janvier de chaque année. Les montants ci-dessus sont les montants actuels s'ils sont reçus au plus tard le 31 décembre de l'année en cours.
Veuillez vous référer à la page web des taxes sur les brevets de l'OPIC pour voir tous les montants actuels des taxes.

Titulaires au dossier

Les titulaires actuels et antérieures au dossier sont affichés en ordre alphabétique.

Titulaires actuels au dossier
THE MICROBIO GROUP LIMITED
Titulaires antérieures au dossier
DEBORAH J. ELLIS
MARTIN P. MEADOWS
PAUL JARRETT
Les propriétaires antérieurs qui ne figurent pas dans la liste des « Propriétaires au dossier » apparaîtront dans d'autres documents au dossier.
Documents

Pour visionner les fichiers sélectionnés, entrer le code reCAPTCHA :



Pour visualiser une image, cliquer sur un lien dans la colonne description du document (Temporairement non-disponible). Pour télécharger l'image (les images), cliquer l'une ou plusieurs cases à cocher dans la première colonne et ensuite cliquer sur le bouton "Télécharger sélection en format PDF (archive Zip)" ou le bouton "Télécharger sélection (en un fichier PDF fusionné)".

Liste des documents de brevet publiés et non publiés sur la BDBC .

Si vous avez des difficultés à accéder au contenu, veuillez communiquer avec le Centre de services à la clientèle au 1-866-997-1936, ou envoyer un courriel au Centre de service à la clientèle de l'OPIC.

({010=Tous les documents, 020=Au moment du dépôt, 030=Au moment de la mise à la disponibilité du public, 040=À la délivrance, 050=Examen, 060=Correspondance reçue, 070=Divers, 080=Correspondance envoyée, 090=Paiement})


Description du
Document 
Date
(aaaa-mm-jj) 
Nombre de pages   Taille de l'image (Ko) 
Description 1997-06-17 17 537
Abrégé 1997-06-17 1 14
Revendications 1997-06-17 3 73
Abrégé 1998-04-05 1 11
Description 1998-04-05 18 543
Description 1996-04-14 17 529
Abrégé 1996-04-14 1 11
Revendications 1996-04-14 2 52
Avis du commissaire - Demande jugée acceptable 1997-10-06 1 164
Courtoisie - Certificat d'enregistrement (document(s) connexe(s)) 2012-10-08 1 102
Correspondance 1998-04-05 4 107
Correspondance 1997-10-06 1 101
Taxes 1996-09-02 1 78
Correspondance de la poursuite 1995-01-16 1 41
Correspondance de la poursuite 1997-02-23 4 158
Demande de l'examinateur 1996-08-22 2 119
Correspondance de la poursuite 1995-07-11 2 57
Courtoisie - Lettre du bureau 1994-12-05 2 82
Courtoisie - Lettre du bureau 1995-05-08 1 29
Correspondance reliée au PCT 1996-03-05 2 75
Courtoisie - Lettre du bureau 1996-03-14 1 18
Courtoisie - Lettre du bureau 1996-03-14 1 15